Sandra Weiss, M.D., FACC
Interventional Cardiologist, Medical Director CardiacIntensive Care Unit ChristianaCare
- Wilmington DE
Sandra Weiss is an interventional cardiologist, with a special interest in both coronary and peripheral interventions.
Biography
Areas of Expertise
Education
Northwestern University
B.S.
2000
University of Chicago Pritzker School of Medicine
M.D.
2004
Multimedia
Links and Image Galleries
Media Appearances
Bystander Rescue Breathing CPR in Kids Tied to Better Survival
Medscape online
2021-08-30
Sandra Weiss, MD, an interventional cardiologist and the medical director of the cardiac intensive care unit at ChristinaCare..
Selected Papers and Publications
Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals
Circulation2010-05-03
Individuals with exaggerated exercise blood pressure (BP) tend to develop future hypertension. It is controversial whether they have higher risk of death from cardiovascular disease (CVD).
Long-term use of dual antiplatelets for the secondary prevention of atherothrombotic events in patients with and without mi: meta-analysis of randomized controlled trials
Journal of American College of Cardiology2016
The potential benefit of long-term dual antiplatelet therapy (DAPT) for secondary prevention of atherothrombotic events is unclear. Data from different randomized controlled trials (RCT) using different agents in different subgroups showed inconsistent results.
Academic Versus Private Cardiology: Preparing for Successful Career after Fellowship
Journal of the American College of Cardiology2015
Cardiovascular diseases are still considered the leading cause of death in the United States. It is estimated that 40% of Americans will experience some form of cardiovascular disease by 2030.
Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease
Progress in Cardiovascular Diseases2015
The keynote COURAGE and BARI-2D trials changed the way the interventional community selects patients for revascularization. What we now consider appropriate, especially for percutaneous coronary intervention, has narrowed significantly in scope compared to previous practice a decade ago.
Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?
JACC: Cardiovascular Interventions2015
The planning of revascularization strategy for multivessel coronary artery disease (CAD) in nondiabetic patients is optimally made through considering the goals of improving survival and/or relieving symptoms.
External Service & Affiliations
- American College of Cardiology : Fellow
Selected Honors & Awards
American Medical Women's Association Award
Received from the University of Chicago in 2004.
ChristianaCare Internal Medicine Residence Clinical Peals Award
ChristianaCare Internal Medicine Residency Clinical Pearls Award 2020.
MD Distinguished Educator Award
ChristianaCare Department of Medicine Virginia U. Collier, MD Distinguished Educator Award 2020.
